Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women - Wikidata - wikimedia - TriplyDB

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

http://www.wikidata.org/entity/Q28251695

about

The pharmacological management of osteoporosis European guidance for the diagnosis and management of osteoporosis in postmenopausal women Drugs for pre-osteoporosis: prevention or disease mongering?Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Surgical prevention of femoral neck fractures in elderly osteoporotic patients. A literature review Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer Molecular cancer prevention: Current status and future directions The evolution of selective estrogen receptor modulators in osteoporosis therapy The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice Screening, diagnosis and treatment of osteoporosis: a brief review An overview on the treatment of postmenopausal osteoporosis Breast cancer chemoprevention: old and new approaches Rapid phenotyping of knockout mice to identify genetic determinants of bone strength Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches Medical prevention of breast cancer Postmenopausal hormones and coronary artery disease: potential benefits and risks Menopause and stroke and the effects of hormonal therapy Update on bazedoxifene: a novel selective estrogen receptor modulator Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk An NO donor approach to neuroprotective and procognitive estrogen therapy overcomes loss of NO synthase function and potentially thrombotic risk Evaluating the potential bioactivity of a novel compound ER1626 Efficacy of Osteoporosis Therapies in Diabetic Patients.Atypical hyperplasia of the breast--risk assessment and management options.Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes Estrogen agonists/antagonists in combination with estrogen for prevention and treatment of menopause-associated signs and symptoms.Advances in the treatment of menopausal symptoms.Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.Ongoing data from the breast cancer prevention trials: opportunity for breast cancer risk reduction.Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia Postmenopausal hormone use and symptoms of gastroesophageal reflux Pharmacology and clinical applications of selective estrogen receptor modulators.Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates.Balance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones.Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease.Current strategies for the prevention of breast cancer Prevention, diagnosis and treatment of osteoporosis following menopause induced due to oncological disease.Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.Osteoporosis: the current status of mesenchymal stem cell-based therapy.Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer.Cancer prevention research - then and now

P2860

Q24605290-3FFE35AB-CAB6-4940-81BD-6554DD65E391 Q24612411-19F0AF04-207E-4EF5-9A46-D4B80CAA90BC Q24649128-92AC312B-BD50-4C17-94BF-0F377FEC3A52 Q24658109-B972E804-9F55-4F5F-BC76-5A217C36C0B8 Q26744057-C4FB13F7-4432-4933-810F-FE7F77EA8BEC Q26769917-7E95EE99-C637-46EA-95E9-421633D8B59E Q26797207-67293AD5-7F8B-4588-9028-E9AC93C16036 Q26827973-F67DB3C8-9FAC-4C07-B292-1ACAA666D87E Q26830744-34532906-D294-4033-9371-FCAC9001ECAF Q26996726-A993326C-D6AB-48FA-86B9-A3ED07220DCA Q27013070-860E28A8-A94D-45ED-A6CD-BABCDE74EA33 Q27693259-D92D50CB-0D30-484B-9BF9-16FB5EE79102 Q28066355-BA33AC09-9763-4052-BAE9-11844FA11082 Q28080472-5F3ED89E-9A72-40B7-93C1-44F6F124DC60 Q28086915-18ECD969-43D1-4342-A96F-AC168349B335 Q28221869-CF0D92F0-0D24-4EAD-98C7-DF29F84F307D Q28221875-033A07CD-BA4C-4A60-A4B3-BFE527F419D3 Q28258998-605786AD-665C-4F05-9988-3E1860B230AD Q28390064-387F1029-E8F7-4942-B226-4AECB8165BA5 Q28535394-19D9A819-45DD-4C53-923D-6A9A19D0C8E5 Q28539181-EE674B10-77FB-4895-94D3-6B657CB8ED18 Q30248776-92ED7883-23A7-4270-8276-9F2D0697BDD8 Q30301033-4C6259BF-E65B-4C41-972D-4023AFFEA4CB Q30409045-F0C72B96-D5F0-4117-A46A-89210DF0E50E Q30447470-FB1E1F36-2450-4589-806B-B462E5BFE50F Q30448720-5EE742FC-1C38-4481-B7E8-D5FFB8A1368F Q30620889-3C0AAD49-5315-4B4F-A6F0-AF5DF4015C37 Q30936399-1F24204A-3FC4-426C-851A-8DC195EED828 Q33282322-E7A29BDF-5095-44F8-A043-63383C037485 Q33367895-CBA8973C-0B4F-4535-8F88-8ABCDAAF41B1 Q33384192-AA6EA8E8-CFBE-4348-AE34-2BEA78D2B2FC Q33395511-55BD8C97-F082-419C-9128-00C747C6862A Q33396534-E3FE8B37-7829-4A9C-B24F-3A6119A93D1A Q33572292-65CD13D0-5AB8-4E05-A749-71E90EBCEFD6 Q33599463-A758D1CB-324D-44D8-BFAB-4F8B66B6F529 Q33610328-F37CB660-3381-48DD-B90E-B15B0AFB0CE1 Q33613016-A1D04486-A6B7-416B-89FA-F0BC7EBFEF78 Q33631498-5FEDD0F9-D728-4457-B947-4B76056654C0 Q33722685-6E2211E9-A5C6-4265-8AB0-A723FC98CBE3 Q33726196-8AB9FBD6-AB86-45FF-BC8D-F48B17B70A9B

P2860

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

http://www.wikidata.org/entity/Q28251695

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@ast

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@en

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@nl

type

label

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@ast

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@en

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@nl

prefLabel

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@ast

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@en

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@nl

P1433

Q28251695-76FEE90D-2E92-41EE-BA5A-3CCA214A1EBC

P1476

Q28251695-2F04FC3F-F131-472E-887B-F7849EF9A0DA

P2093

Q28251695-12866759-7A57-45D7-BDDB-8E7290D64C37

Q28251695-58F599A4-0962-4086-A69C-C46C48148372

Q28251695-7A9C748A-380C-4CEA-BEFA-8B1E6E76C852

Q28251695-A69FD89B-921C-4CEB-8456-A39D608A0092

Q28251695-BE7607B1-782E-4A9D-A156-6AF2A8312D6E

Q28251695-F2B7F1B3-8AE7-45A2-864C-FA3FDBE4D1E6

Q28251695-F5F541BE-A861-49A1-A55C-6D0A5F11B49D

P304

Q28251695-D17B1A3C-B105-4C5E-AABF-4166CB7C4DEC

P31

Q28251695-E6D95309-975B-451D-97A0-82672E450255

P3181

Q28251695-54692B2F-F0D5-4808-BB18-225217502C17

P356

Q28251695-7FF9AB14-7925-42AF-8B7E-21A2ADE0E43B

P407

Q28251695-44B61B39-C336-4449-82DE-CAE8E61B1918

P433

Q28251695-58E15746-4C1A-407E-874D-DD14244834E2

P478

Q28251695-8C980BA4-45D1-4B0B-901C-495567FE778B

P50

Q28251695-7BBD8128-78D6-4CDB-89F2-C4995ADD110D

P577

Q28251695-9C8322F7-DF5B-4D3C-A739-361459DA5323

P698

Q28251695-7F954E8F-8B9A-4C04-9E4F-D5B3A424335E

P921

Q28251695-9A6FF0AB-7654-4F14-8066-08DB282BB59A

P3181

P356

P1433

The New England Journal of Medicine

P1476

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

@en

P2093

Deborah Grady

http://www.w3.org/2001/XMLSchema#string

Lori Mosca

http://www.w3.org/2001/XMLSchema#string

Marcel Kornitzer

http://www.w3.org/2001/XMLSchema#string

Mary Jane Geiger

http://www.w3.org/2001/XMLSchema#string

Michelle A McNabb

http://www.w3.org/2001/XMLSchema#string

Nanette K Wenger

http://www.w3.org/2001/XMLSchema#string

Peter Collins

http://www.w3.org/2001/XMLSchema#string

P304

125-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4042575

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA062462

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

355

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Barrett-Connor

P577

2006-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16837676

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio